{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:28:36Z","timestamp":1794241716319,"version":"4.9.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-04086-1","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:37:06Z","timestamp":1764250626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The CCAT2 enigma: pioneering insights into colorectal cancer pathophysiology and therapeutic innovation"],"prefix":"10.1186","volume":"26","author":[{"given":"Maryam","family":"Fathollahzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Ghorbani","family":"Vanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafise","family":"Mohammadmoradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Ghorbaninezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooya","family":"Eini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Tofighi Zavareh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasamin","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Tahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Safarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"6","key":"4086_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"4086_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683\u201391.","journal-title":"Gut"},{"issue":"15","key":"4086_CR3","doi-asserted-by":"publisher","first-page":"e34375","DOI":"10.1016\/j.heliyon.2024.e34375","volume":"10","author":"Y Goudarzi","year":"2024","unstructured":"Goudarzi Y, Monirvaghefi K, Aghaei S, Amiri SS, Rezaei M, Dehghanitafti A, et al. Effect of genetic profiling on surgical decisions at hereditary colorectal cancer syndromes. Heliyon. 2024;10(15):e34375.","journal-title":"Heliyon"},{"issue":"10207","key":"4086_CR4","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JL, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467\u201380.","journal-title":"Lancet"},{"key":"4086_CR5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"key":"4086_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.65","author":"EJ Kuipers","year":"2015","unstructured":"Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, et al. Colorectal cancer. Nat Rev Dis Primers. 2015. https:\/\/doi.org\/10.1038\/nrdp.2015.65.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"4086_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1053\/j.gastro.2017.05.013","volume":"153","author":"DK Rex","year":"2017","unstructured":"Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, et al. Colorectal cancer screening: recommendations for physicians and patients from the US multi-society task force on colorectal cancer. Gastroenterology. 2017;153(1):307\u201323.","journal-title":"Gastroenterology"},{"issue":"3","key":"4086_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ccr.2007.07.027","volume":"12","author":"GA Calin","year":"2007","unstructured":"Calin GA, Liu C-g, Ferracin M, Hyslop T, Spizzo R, Sevignani C, et al. Ultraconserved regions encoding NcRNAs are altered in human leukemias and carcinomas. Cancer Cell. 2007;12(3):215\u201329.","journal-title":"Cancer Cell"},{"key":"4086_CR9","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1007\/s13277-015-3220-x","volume":"36","author":"J Wang","year":"2015","unstructured":"Wang J, Qiu M, Xu Y, Li M, Dong G, Mao Q, et al. Long noncoding RNA CCAT2 correlates with smoking in esophageal squamous cell carcinoma. Tumor Biol. 2015;36:5523\u20138.","journal-title":"Tumor Biol"},{"issue":"1","key":"4086_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-025-01711-1","volume":"25","author":"A Ghorbani vanan","year":"2025","unstructured":"Ghorbani vanan A, Nami MT, Ghorbaninezhad F, Eini P, Bagheri K, Mohammadlou M, et al. Macrophage polarization in hepatocellular carcinoma: a lncRNA-centric perspective on tumor progression and metastasis. Clin Exp Med. 2025;25(1):173.","journal-title":"Clin Exp Med"},{"issue":"1","key":"4086_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12935-025-04017-0","volume":"25","author":"F Ghorbaninezhad","year":"2025","unstructured":"Ghorbaninezhad F, Vanan AG, Rostami S, Vaezi F, Doachi R, Hafshejani ZA, et al. Long non-coding rnas: key orchestrators of macrophage polarization in breast cancer. Cancer Cell Int. 2025;25(1):372.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4086_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10238-025-01730-y","volume":"25","author":"AG Vanan","year":"2025","unstructured":"Vanan AG, Ghorbaninezhad F, Nikeghbali G, Mohamadi F, Ayati A, Mastani RG, et al. CCAT2 role in gastrointestinal cancer progression and metastasis: a novel target for therapeutic strategies. Clin Exp Med. 2025;25(1):197.","journal-title":"Clin Exp Med"},{"issue":"2","key":"4086_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.gene.2014.11.060","volume":"556","author":"Y Xue","year":"2015","unstructured":"Xue Y, Ma G, Gu D, Zhu L, Hua Q, Du M, et al. Genome-wide analysis of long noncoding RNA signature in human colorectal cancer. Gene. 2015;556(2):227\u201334.","journal-title":"Gene"},{"issue":"6","key":"4086_CR14","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3727\/096504016X14792098307036","volume":"25","author":"J Zeng","year":"2017","unstructured":"Zeng J, Du T, Song Y, Gao Y, Li F, Wu R, et al. Knockdown of long noncoding RNA CCAT2 inhibits cellular proliferation, invasion, and epithelial\u2013mesenchymal transition in glioma cells. Oncol Res. 2017;25(6):913.","journal-title":"Oncol Res"},{"issue":"6","key":"4086_CR15","doi-asserted-by":"publisher","first-page":"e0286486","DOI":"10.1371\/journal.pone.0286486","volume":"18","author":"C Franz","year":"2023","unstructured":"Franz C, Wuehrl M, Hartmann S, Klupp F, Schmidt T, Schneider M. Long non-coding RNAs CCAT1 and CCAT2 in colorectal liver metastases are tumor-suppressive via MYC interaction and might predict patient outcomes. PLoS One. 2023;18(6):e0286486.","journal-title":"PLoS One"},{"issue":"4","key":"4086_CR16","first-page":"1840","volume":"25","author":"P Gao","year":"2020","unstructured":"Gao P, Sun D, Guo H, Wu Z, Chen J. LncRNA CCAT2 promotes proliferation and suppresses apoptosis of colorectal cancer cells. J Buon. 2020;25(4):1840\u20136.","journal-title":"J Buon"},{"issue":"10","key":"4086_CR17","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.2174\/0115680096274757231219072003","volume":"24","author":"Y Xing","year":"2024","unstructured":"Xing Y, Lin B, Liu B, Shao J, Jin Z. Tectorigenin inhibits glycolysis-induced cell growth and proliferation by modulating LncRNA CCAT2\/miR-145 pathway in colorectal cancer. Curr Cancer Drug Targets. 2024;24(10):1071\u20139.","journal-title":"Curr Cancer Drug Targets"},{"issue":"22","key":"4086_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212491","volume":"22","author":"R Pirlog","year":"2021","unstructured":"Pirlog R, Drula R, Nutu A, Calin GA, Berindan-Neagoe I. The roles of the colon cancer associated transcript 2 (CCAT2) long non-coding RNA in cancer: a comprehensive characterization of the tumorigenic and molecular functions. Int J Mol Sci. 2021;22(22):12491.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4086_CR19","first-page":"6907","volume":"14","author":"J Zhang","year":"2017","unstructured":"Zhang J, Jiang Y, Zhu J, Wu T, Ma J, Du C, et al. Overexpression of long non-coding RNA colon cancer-associated transcript 2 is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer. Oncol Lett. 2017;14(6):6907\u201314.","journal-title":"Oncol Lett"},{"key":"4086_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-017-0725-5","volume":"16","author":"Y Yu","year":"2017","unstructured":"Yu Y, Nangia-Makker P, Farhana L, Majumdar AP. A novel mechanism of LncRNA and MiRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells. Mol Cancer. 2017;16:1\u201311.","journal-title":"Mol Cancer"},{"issue":"16","key":"4086_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16162833","volume":"16","author":"E-R Wu","year":"2019","unstructured":"Wu E-R, Hsieh M-J, Chiang W-L, Hsueh K-C, Yang S-F, Su S-C. Association of LncRNA CCAT2 and CASC8 gene polymorphisms with hepatocellular carcinoma. Int J Environ Res Public Health. 2019;16(16):2833.","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"4086_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076294","volume":"24","author":"I Riquelme","year":"2023","unstructured":"Riquelme I, P\u00e9rez-Moreno P, Mora-Lagos B, Ili C, Brebi P, Roa JC. Long non-coding RNAs (lncRNAs) as regulators of the PI3K\/AKT\/mTOR pathway in gastric carcinoma. Int J Mol Sci. 2023;24(7):6294.","journal-title":"Int J Mol Sci"},{"key":"4086_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108758","volume":"113","author":"L Wang","year":"2019","unstructured":"Wang L, Duan W, Yan S, Xie Y, Wang C. Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer. Biomed Pharmacother. 2019;113:108758.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"4086_CR24","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1093\/annonc\/mdx248","volume":"28","author":"T Ozawa","year":"2017","unstructured":"Ozawa T, Matsuyama T, Toiyama Y, Takahashi N, Ishikawa T, Uetake H, et al. CCAT1 and CCAT2 long noncoding RNAs, located within the 8q. 24.21 \u2018gene desert\u2019, serve as important prognostic biomarkers in colorectal cancer. Ann Oncol. 2017;28(8):1882\u20138.","journal-title":"Ann Oncol"},{"key":"4086_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.598817","author":"N Gao","year":"2020","unstructured":"Gao N, Li Y, Li J, Gao Z, Yang Z, Li Y, et al. Long non-coding rnas: the regulatory mechanisms, research strategies, and future directions in cancers. Front Oncol. 2020. https:\/\/doi.org\/10.3389\/fonc.2020.598817.","journal-title":"Front Oncol"},{"issue":"7","key":"4086_CR26","doi-asserted-by":"publisher","first-page":"11356","DOI":"10.18632\/oncotarget.14529","volume":"8","author":"X Ke","year":"2017","unstructured":"Ke X, Yuan Y, Guo C, Yang Y, Pu Q, Hu X, et al. Mir-410 induces stemness by inhibiting Gsk3\u03b2 but upregulating \u03b2-catenin in non-small cells lung cancer. Oncotarget. 2017;8(7):11356.","journal-title":"Oncotarget"},{"issue":"10","key":"4086_CR27","first-page":"2978","volume":"22","author":"R Ruan","year":"2018","unstructured":"Ruan R, Zhao X. LncRNA CCAT2 enhances cell proliferation via GSK3\u03b2\/\u03b2-catenin signaling pathway in human osteosarcoma. Eur Rev Med Pharmacol Sci. 2018;22(10):2978\u201384.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"23","key":"4086_CR28","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1097\/CM9.0000000000002286","volume":"135","author":"S Ma","year":"2022","unstructured":"Ma S, Wang W, Zhang D, Zhao G, Lu Z. Long non-coding RNA colon cancer-associated transcript 2: role and function in human cancers. Chin Med J. 2022;135(23):2785\u201397.","journal-title":"Chin Med J"},{"issue":"1","key":"4086_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000452143","volume":"92","author":"Y Kasagi","year":"2017","unstructured":"Kasagi Y, Oki E, Ando K, Ito S, Iguchi T, Sugiyama M, et al. The expression of CCAT2, a novel long noncoding RNA transcript, and rs6983267 single-nucleotide polymorphism genotypes in colorectal cancers. Oncology. 2017;92(1):48\u201354.","journal-title":"Oncology"},{"issue":"1","key":"4086_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/CBM-170388","volume":"21","author":"P Xie","year":"2017","unstructured":"Xie P, Cao H, Li Y, Wang J, Cui Z. Knockdown of LncRNA CCAT2 inhibits endometrial cancer cells growth and metastasis via sponging miR-216b. Cancer Biomark. 2017;21(1):123\u201333.","journal-title":"Cancer Biomark"},{"issue":"4","key":"4086_CR31","first-page":"4600","volume":"16","author":"C Zhao","year":"2018","unstructured":"Zhao C, Qiao C, Zong L, Chen Y. Long non\u2013coding RNA\u2013CCAT2 promotes the occurrence of non\u2013small cell lung cancer by regulating the Wnt\/\u03b2\u2013catenin signaling pathway. Oncol Lett. 2018;16(4):4600\u20136.","journal-title":"Oncol Lett"},{"key":"4086_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121183","volume":"311","author":"F Moradi","year":"2022","unstructured":"Moradi F, Mohajerani F, Sadeghizadeh M. CCAT2 knockdown inhibits cell growth, and migration and promotes apoptosis through regulating the hsa-mir-145-5p\/AKT3\/mTOR axis in tamoxifen-resistant MCF7 cells. Life Sci. 2022;311:121183.","journal-title":"Life Sci"},{"issue":"1","key":"4086_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3892\/ol.2016.4580","volume":"12","author":"N Zhou","year":"2016","unstructured":"Zhou N, Si Z, Li T, Chen G, Zhang Z, Qi H. Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis. Oncol Lett. 2016;12(1):132\u20138.","journal-title":"Oncol Lett"},{"key":"4086_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.biopha.2018.01.061","volume":"99","author":"Y Xu","year":"2018","unstructured":"Xu Y, Yao Y, Qin W, Zhong X, Jiang X, Cui Y. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition. Biomed Pharmacother. 2018;99:121\u20137.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4086_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11010-020-03712-y","volume":"468","author":"S-L Sun","year":"2020","unstructured":"Sun S-L, Shu Y-G, Tao M-Y. LncRNA CCAT2 promotes angiogenesis in glioma through activation of VEGFA signalling by sponging miR-424. Mol Cell Biochem. 2020;468(1):69\u201382.","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"4086_CR36","first-page":"3369","volume":"15","author":"B Wang","year":"2018","unstructured":"Wang B, Liu M, Zhuang R, Jiang J, Gao J, Wang H, et al. Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt\/\u03b2-catenin pathway in epithelial ovarian carcinoma cells. Oncol Lett. 2018;15(3):3369\u201375.","journal-title":"Oncol Lett"},{"key":"4086_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111279","volume":"137","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Abak A, Anamag FT, Shoorei H, Majidpoor J, Taheri M. The emerging role of non-coding RNAs in the regulation of PI3K\/AKT pathway in the carcinogenesis process. Biomed Pharmacother. 2021;137:111279.","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"4086_CR38","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.7150\/ijbs.27977","volume":"14","author":"X-Y Hu","year":"2018","unstructured":"Hu X-Y, Hou P-F, Li T-T, Quan H-Y, Li M-L, Lin T, et al. The roles of Wnt\/\u03b2-catenin signaling pathway related lncRNAs in cancer. Int J Biol Sci. 2018;14(14):2003.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"4086_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. The MYC oncogene\u2014the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2022;19(1):23\u201336.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"4086_CR40","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211019938","volume":"49","author":"C Yang","year":"2021","unstructured":"Yang C, Li F, Zhou W, Huang J. Knockdown of long non-coding RNA CCAT2 suppresses growth and metastasis of esophageal squamous cell carcinoma by inhibiting the \u03b2-catenin\/WISP1 signaling pathway. J Int Med Res. 2021;49(5):03000605211019938.","journal-title":"J Int Med Res"},{"issue":"1","key":"4086_CR41","first-page":"1","volume":"4","author":"N Zahmatkesh","year":"2024","unstructured":"Zahmatkesh N, Babaei SS, Habibi Manesh S, Abbaspour M, Ghadirzadeh E, Salimian N, et al. Artificial intelligence for prediction of metastasis risk and survival. Kindle. 2024;4(1):1\u2013205.","journal-title":"Kindle"},{"issue":"1","key":"4086_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13058-025-02136-0","volume":"27","author":"F Norouzi","year":"2025","unstructured":"Norouzi F, Eini P, Tahmasebi S. The role of NETosis in breast cancer: mechanistic insights and biomarker potential. Breast Cancer Res. 2025;27(1):180.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"4086_CR43","first-page":"779","volume":"8","author":"CY Wang","year":"2015","unstructured":"Wang CY, Hua L, Yao KH, Chen JT, Zhang JJ, Hu JH. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis. Int J Clin Exp Pathol. 2015;8(1):779\u201385.","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"4086_CR44","first-page":"706","volume":"21","author":"ZJ Wu","year":"2017","unstructured":"Wu ZJ, Li Y, Wu YZ, Wang Y, Nian WQ, Wang LL, et al. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-\u03b2 signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(4):706\u201314.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4086_CR45","first-page":"2657","volume":"8","author":"Y Cai","year":"2015","unstructured":"Cai Y, He J, Zhang D. Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway. Onco Targets Ther. 2015;8:2657\u201364.","journal-title":"Onco Targets Ther"},{"key":"4086_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104628","volume":"152","author":"Z Xu","year":"2020","unstructured":"Xu Z, Liu C, Zhao Q, L\u00fc J, Ding X, Luo A, et al. Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells. Pharmacol Res. 2020;152:104628.","journal-title":"Pharmacol Res"},{"key":"4086_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020290","author":"F Yang","year":"2024","unstructured":"Yang F, Yang Y, Qiu Y, Tang L, Xie L, Guan X. Long non-coding RNAs as regulators for targeting breast cancer stem cells and tumor immune microenvironment: biological properties and therapeutic potential. Cancers. 2024. https:\/\/doi.org\/10.3390\/cancers16020290.","journal-title":"Cancers"},{"issue":"9","key":"4086_CR48","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1101\/gr.152942.112","volume":"23","author":"H Ling","year":"2013","unstructured":"Ling H, Spizzo R, Atlasi Y, Nicoloso M, Shimizu M, Redis RS, et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013;23(9):1446\u201361.","journal-title":"Genome Res"},{"key":"4086_CR49","doi-asserted-by":"crossref","unstructured":"Petkevich A, Abramov A, Pospelov V. LncRNAs in cancer development. In: Dabas P, editor. Noncoding RNA - The dark matter of the genome. Rijeka: IntechOpen; 2024.","DOI":"10.5772\/intechopen.114905"},{"issue":"6","key":"4086_CR50","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s13402-023-00835-4","volume":"46","author":"H Deng","year":"2023","unstructured":"Deng H, Gao J, Cao B, Qiu Z, Li T, Zhao R, et al. LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing. Cell Oncol. 2023;46(6):1675\u201390.","journal-title":"Cell Oncol"},{"issue":"4","key":"4086_CR51","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11958","volume":"20","author":"P He","year":"2020","unstructured":"He P, Xiong G, Guo W, Jiang G, Li Y, Li H. Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt\/\u03b2-catenin signaling pathway. Oncol Lett. 2020;20(4):97.","journal-title":"Oncol Lett"},{"issue":"1","key":"4086_CR52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13000-016-0499-x","volume":"11","author":"S Huang","year":"2016","unstructured":"Huang S, Qing C, Huang Z, Zhu Y. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis. Diagn Pathol. 2016;11(1):49.","journal-title":"Diagn Pathol"},{"key":"4086_CR53","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.biopha.2016.12.122","volume":"87","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Wang J, Wang S, Chang H, Zhang T, Qu J. LncRNA CCAT2 promotes tumorigenesis by over-expressed Pokemon in non-small cell lung cancer. Biomed Pharmacother. 2017;87:692\u20137.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"4086_CR54","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1053\/j.gastro.2020.08.018","volume":"159","author":"B Chen","year":"2020","unstructured":"Chen B, Dragomir MP, Fabris L, Bayraktar R, Knutsen E, Liu X, et al. The long noncoding RNA CCAT2 induces chromosomal instability through BOP1-AURKB signaling. Gastroenterology. 2020;159(6):2146\u2013e6233.","journal-title":"Gastroenterology"},{"key":"4086_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12342","author":"Y Xin","year":"2017","unstructured":"Xin Y, Li Z, Zheng H, Chan MTV, Ka Kei Wu W. CCAT2: a novel oncogenic long non-coding RNA in human cancers. Cell Prolif. 2017. https:\/\/doi.org\/10.1111\/cpr.12342.","journal-title":"Cell Prolif"},{"issue":"1","key":"4086_CR56","doi-asserted-by":"publisher","first-page":"16246","DOI":"10.1038\/s41598-017-16500-4","volume":"7","author":"OG Shaker","year":"2017","unstructured":"Shaker OG, Senousy MA, Elbaz EM. Association of rs6983267 at 8q24, HULC rs7763881 polymorphisms and serum LncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients. Sci Rep. 2017;7(1):16246.","journal-title":"Sci Rep"},{"key":"4086_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/biom15111564","author":"S Tahmasebi","year":"2025","unstructured":"Tahmasebi S, Amani D, Salimi B, Adcock IM, Mortaz E. LncRNA-mediated miR-145 sponging drives FN1 and CCND1 expression: prognostic and therapeutic targets in NSCLC. Biomolecules. 2025. https:\/\/doi.org\/10.3390\/biom15111564.","journal-title":"Biomolecules"},{"issue":"8","key":"4086_CR58","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1089\/gtmb.2018.0308","volume":"23","author":"H Siddique","year":"2019","unstructured":"Siddique H, Al-Ghafari A, Choudhry H, AlTurki S, Alshaibi H, Al Doghaither H, et al. Long noncoding RNAs as prognostic markers for colorectal cancer in Saudi patients. Genet Test Mol Biomarkers. 2019;23(8):509\u201314.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"1","key":"4086_CR59","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21(1):144.","journal-title":"Mol Cancer"},{"issue":"17","key":"4086_CR60","doi-asserted-by":"publisher","first-page":"8613","DOI":"10.18632\/aging.204560","volume":"15","author":"QY Yu","year":"2023","unstructured":"Yu QY, Han Y, Lu JH, Sun YJ, Liao XH. NRP1 regulates autophagy and proliferation of gastric cancer through Wnt\/\u03b2-catenin signaling pathway. Aging. 2023;15(17):8613\u201329.","journal-title":"Aging"},{"key":"4086_CR61","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.canlet.2021.10.034","volume":"525","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Xu J, Luo H, Meng X, Chen M, Zhu D. Wnt signaling pathway in cancer immunotherapy. Cancer Lett. 2022;525:84\u201396.","journal-title":"Cancer Lett"},{"issue":"3","key":"4086_CR62","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.arcmed.2021.12.001","volume":"53","author":"M Hemmati-Dinarvand","year":"2022","unstructured":"Hemmati-Dinarvand M, Ahmadvand H, Seghatoleslam A. Nitazoxanide and cancer drug resistance: targeting Wnt\/\u03b2-catenin signaling pathway. Arch Med Res. 2022;53(3):263\u201370.","journal-title":"Arch Med Res"},{"issue":"1","key":"4086_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01851-y","volume":"9","author":"X Chu","year":"2024","unstructured":"Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z, et al. Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduct Target Ther. 2024;9(1):170.","journal-title":"Signal Transduct Target Ther"},{"key":"4086_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.751903","volume":"11","author":"D Wang","year":"2021","unstructured":"Wang D, Li Z, Yin H. Long non-coding RNA CCAT2 activates RAB14 and acts as an oncogene in colorectal cancer. Front Oncol. 2021;11:751903.","journal-title":"Front Oncol"},{"issue":"12","key":"4086_CR65","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1080\/14728222.2018.1541453","volume":"22","author":"J Fo\u00dfelteder","year":"2018","unstructured":"Fo\u00dfelteder J, Calin GA, Pichler M. Long non-coding RNA CCAT2 as a therapeutic target in colorectal cancer. Expert Opin Ther Targets. 2018;22(12):973\u20136.","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"4086_CR66","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.molcel.2016.01.015","volume":"61","author":"RS Redis","year":"2016","unstructured":"Redis RS, Vela LE, Lu W, Ferreira de Oliveira J, Ivan C, Rodriguez-Aguayo C, et al. Allele-Specific reprogramming of cancer metabolism by the long Non-coding RNA CCAT2. Mol Cell. 2016;61(4):520\u201334.","journal-title":"Mol Cell"},{"issue":"7","key":"4086_CR67","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.18632\/aging.103006","volume":"12","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Liu H, Liu X, Guo Y, Wang Y, Dai Y, et al. Identification of an exosomal long non-coding RNAs panel for predicting recurrence risk in patients with colorectal cancer. Aging. 2020;12(7):6067\u201388.","journal-title":"Aging"},{"key":"4086_CR68","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cca.2017.01.016","volume":"466","author":"YH Fan","year":"2017","unstructured":"Fan YH, Fang H, Ji CX, Xie H, Xiao B, Zhu XG. Long noncoding RNA CCAT2 can predict metastasis and poor prognosis: a meta-analysis. Clin Chim Acta. 2017;466:120\u20136.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"4086_CR69","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41598-020-79906-7","volume":"11","author":"LF Thean","year":"2021","unstructured":"Thean LF, Bl\u00f6cker C, Li HH, Lo M, Wong M, Tang CL, et al. Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasis. Sci Rep. 2021;11(1):404.","journal-title":"Sci Rep"},{"issue":"5","key":"4086_CR70","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/jcmm.17041","volume":"26","author":"D Zhou","year":"2022","unstructured":"Zhou D, Gu J, Wang Y, Luo B, Feng M, Wang X. Long noncoding RNA CCAT2 reduces chemosensitivity to 5-fluorouracil in breast cancer cells by activating the mTOR axis. J Cell Mol Med. 2022;26(5):1392\u2013401.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"4086_CR71","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.3390\/curroncol28060447","volume":"28","author":"K Chen","year":"2021","unstructured":"Chen K, Collins G, Wang H, Toh JWT. Pathological features and prognostication in colorectal cancer. Curr Oncol. 2021;28(6):5356\u201383.","journal-title":"Curr Oncol"},{"issue":"1","key":"4086_CR72","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12935-023-02867-0","volume":"23","author":"Y Wu","year":"2023","unstructured":"Wu Y, Xu X. Long non-coding RNA signature in colorectal cancer: research progression and clinical application. Cancer Cell Int. 2023;23(1):28.","journal-title":"Cancer Cell Int"},{"key":"4086_CR73","doi-asserted-by":"publisher","DOI":"10.2174\/0115680096274757231219072003","author":"Y Xing","year":"2024","unstructured":"Xing Y, Lin B, Liu B, Shao J, Jin Z. Tectorigenin inhibits glycolysis-induced cell growth and proliferation by modulating LncRNA CCAT2\/miR-145 pathway in colorectal cancer. Curr Cancer Drug Targets. 2024. https:\/\/doi.org\/10.2174\/0115680096274757231219072003.","journal-title":"Curr Cancer Drug Targets"},{"key":"4086_CR74","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.omtn.2018.05.009","volume":"12","author":"C Barbagallo","year":"2018","unstructured":"Barbagallo C, Brex D, Caponnetto A, Cirnigliaro M, Scalia M, Magnano A, et al. LncRNA UCA1, upregulated in CRC biopsies and downregulated in serum exosomes, controls mRNA expression by RNA-RNA interactions. Mol Ther Nucleic Acids. 2018;12:229\u201341.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"34","key":"4086_CR75","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.3748\/wjg.v25.i34.5026","volume":"25","author":"O Galamb","year":"2019","unstructured":"Galamb O, Bart\u00e1k BK, Kalm\u00e1r A, Nagy ZB, Szigeti KA, Tulassay Z, et al. Diagnostic and prognostic potential of tissue and circulating long non-coding RNAs in colorectal tumors. World J Gastroenterol. 2019;25(34):5026\u201348.","journal-title":"World J Gastroenterol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04086-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-04086-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04086-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:21:01Z","timestamp":1768922461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-025-04086-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4086"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-04086-1","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}